Login to Your Account



Clinic Roundup


Thursday, October 4, 2012
• Depomed Inc., of Menlo Park, Calif., presented additional data from its Phase III trial, BREEZE 3, suggesting Serada, its nonhormonal extended-release formulation of gabapentin, may help manage menopausal hot flashes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription